Phathom Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to innovating and commercializing therapeutic solutions for gastrointestinal disorders. Headquartered in Florham Park, New Jersey, Phathom is at the forefront of advancing novel treatment options aimed at addressing significant unmet medical needs in the gastrointestinal space. With a robust pipeline and a strategic approach to clinical development, the company is positioned to make a meaningful impact on patient care while driving long-term shareholder value.